ITX-2155

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameITX-2155

Drug Alias NameOncoMettumor cell mitochondrial function and tumor survival GRP78 protein inhibitors (ItherX)tumor cell mitochondrial function and tumor survival glucose-regulated protein inhibitors (iTherX)ITX-2155

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of Action78 kDa glucose-regulated protein inhibitors

Targets78 kDa glucose-regulated protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesItherx Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesItherx Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A